Cargando…

Pediatric Medulloblastoma – Update on Molecular Classification Driving Targeted Therapies

As advances in the molecular and genetic profiling of pediatric medulloblastoma evolve, associations with prognosis and treatment are found (prognostic and predictive biomarkers) and research is directed at molecular therapies. Medulloblastoma typically affects young patients, where the implications...

Descripción completa

Detalles Bibliográficos
Autores principales:	DeSouza, Ruth-Mary, Jones, Benjamin R. T., Lowis, Stephen P., Kurian, Kathreena M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105823/ https://www.ncbi.nlm.nih.gov/pubmed/25101241 http://dx.doi.org/10.3389/fonc.2014.00176

Ejemplares similares

Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas
por: Penman, Catherine Louise, et al.
Publicado: (2015)

Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
por: Williams, Maria J., et al.
Publicado: (2017)

Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment
por: Haynes, Harry R., et al.
Publicado: (2014)

Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
por: Ellis, Hayley Patricia, et al.
Publicado: (2014)

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015)

Targeting the Ubiquitin System in Glioblastoma
por: Scholz, Nico, et al.
Publicado: (2020)

Molecular Classification of Medulloblastoma
por: KIJIMA, Noriyuki, et al.
Publicado: (2016)

Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
por: Carta, Roberto, et al.
Publicado: (2020)

Current Advances in Checkpoint Inhibitors: Lessons from Non-Central Nervous System Cancers and Potential for Glioblastoma
por: Lakin, Natasha, et al.
Publicado: (2017)

Pre-diagnostic blood biomarkers for adult glioma
por: Andrews, Lily J., et al.
Publicado: (2023)

Prognostic significance of molecular subgroups in survival outcome for children with medulloblastoma in Malaysia
por: Rajagopal, Revathi, et al.
Publicado: (2023)

Medulloblastoma: molecular pathways and histopathological classification
por: Borowska, Anna, et al.
Publicado: (2016)

Novel Molecular Hallmarks of Group 3 Medulloblastoma by Single-Cell Transcriptomics
por: Qin, Chaoying, et al.
Publicado: (2021)

Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
por: Ellis, Hayley P., et al.
Publicado: (2015)

Update on molecular and genetic alterations in adult medulloblastoma
por: Kool, Marcel, et al.
Publicado: (2012)

Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies
por: Harland, Abigail, et al.
Publicado: (2021)

Medulloblastoma and the DNA Damage Response
por: McSwain, Leon F., et al.
Publicado: (2022)

Radiation Induced Cavernomas in the Treatment of Pediatric Medulloblastoma: Comparative Study Between Proton and Photon Radiation Therapy
por: Trybula, S. Joy, et al.
Publicado: (2021)

Targeting the Hedgehog Pathway in Pediatric Medulloblastoma
por: Huang, Sherri Y., et al.
Publicado: (2015)

Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study
por: Iyer, Sukanya, et al.
Publicado: (2022)

Erratum: Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study
Publicado: (2023)

In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)

Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma
por: Zhang, Jin, et al.
Publicado: (2022)

Linked-read based analysis of the medulloblastoma genome
por: Zwaig, Melissa, et al.
Publicado: (2023)

Update on the integrated histopathological and genetic classification of medulloblastoma – a practical diagnostic guideline
por: Pietsch, Torsten, et al.
Publicado: (2016)

An Update From the Pediatric Proton Consortium Registry
por: Hess, Clayton B., et al.
Publicado: (2018)

Downregulation of 14q32 microRNAs in Primary Human Desmoplastic Medulloblastoma
por: Lucon, Danielle Ribeiro, et al.
Publicado: (2013)

Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma
por: Yan, Jing, et al.
Publicado: (2020)

PTCL, NOS: An update on classification, risk-stratification, and treatment
por: Weiss, Jonathan, et al.
Publicado: (2023)

Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery
por: Srinivasan, Visish M., et al.
Publicado: (2016)

Modeling pediatric medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2019)

Pathology, diagnostics, and classification of medulloblastoma
por: Orr, Brent A.
Publicado: (2020)

Resection cavity auto‐contouring for patients with pediatric medulloblastoma using only CT information
por: Hernandez, Soleil, et al.
Publicado: (2023)

Targeting H3K27me3 demethylase to inhibit Shh signaling and cholesterol metabolism in medulloblastoma growth
por: Deng, Hongshi, et al.
Publicado: (2022)

LINC-03. MOLECULAR CLASSIFICATION OF PAEDIATRIC MEDULLOBLASTOMA FROM FOUR TERTIARY CENTRES IN MALAYSIA: DIAGNOSTIC DILEMMA WITH CONVENTIONAL METHODS
por: Rajagopal, Revathi, et al.
Publicado: (2020)

ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma
por: Ingram, Wendy J, et al.
Publicado: (2013)

Bilateral Simultaneous Temporal Relapses of Medulloblastoma
por: Martinez-Moreno, Mauricio, et al.
Publicado: (2018)

The Combination of Novel Targeted Molecular Agents and Radiation in the Treatment of Pediatric Gliomas
por: Dasgupta, Tina, et al.
Publicado: (2013)

Targeting the medulloblastoma: a molecular-based approach
por: Luzzi, Sabino, et al.
Publicado: (2020)

MBRS-38. MOLECULAR CLASSIFICATION AND CLINICAL CHARACTERISTICS OF 236 MEDULLOBLASTOMAS IN JAPAN
por: Kanemura, Yonehiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qm0rf0hfdkkmp0rih5e03m5ihv